Claims for Patent: 10,004,819

Summary for Patent: 10,004,819

Title:	Tissue allograft sterilization method
Abstract:	The invention is a novel method of sterilizing bone and soft tissues intended for human transplantation. In one embodiment the process includes steps of subjecting transplants to high hydrostatic pressures of aqueous fluid to which chlorhexidine gluconate or similar sterilizing chemicals have been added.
Inventor(s):	Malinin; Theodore I (Key Biscayne, FL)
Assignee:	Vivex Biomedical, Inc. (Atlanta, GA)
Application Number:	14/300,462
Patent Claims:	1. A method for producing a bone graft suitable for transplantation into a human from cadaver bone, the method comprising the steps of: (a) initially washing the cadaver bone; (b) exposing the washed cadaver bone to a jet stream from a water jet system, which has been adjusted below a cutting capacity of the water jet system, to form a jet stream-washed bone graft; (c) delivery of one or more sterilizing solutions containing chlorhexidine gluconate, Dakin solution, chloramineT and/or other solutions generating hypochlorous acid to the jet stream-washed bone graft using a high pressure chamber having a high hydrostatic pressure so as to achieve microbial inactivation of the bone graft; (d) re-washing the microbial inactivated bone graft under high hydrostatic pressure in the range of 100-600 MPa to remove residuals of the one or more sterilizing solutions; and (e) immersing the re-washed bone graft in Dakin solution or other solution producing hypochlorous acid at normal atmospheric pressure. 2. The method of claim 1, wherein in step (c) the bone graft is treated with a 0.5% to 5% solution of chlorhexidine gluconate. 3. The method of claim 1, further comprising washing the bone graft with distilled water after step (e). 4. The method of claim 1, further comprising washing the bone graft with distilled water after step (e). 5. The method of claim 1, wherein in step (c) the sterilizing solution contains chlorhexidine gluconate and the high hydrostatic pressure is in the range of 50-400 MPa. 6. The method of claim 5, further comprising washing the bone graft with distilled water after step (e). 7. The method of claim 5, further comprising washing the bone graft with distilled water after step (e). 8. The method of claim 1, wherein in step (c) the sterilizing solution contains Dakin solution and/or other compounds which produce hypochlorous acid under high hydrostatic pressure, and wherein the high hydrostatic pressure is in the range of 50-400 MPa. 9. The method of claim 8, further comprising washing the bone graft with distilled water after step (e). 10. The method of claim 8, further comprising washing the bone graft with distilled water after step (e). 11. The method of claim 1, wherein in step (b) the jet stream from the water jet system comprises a jet stream of sterile water or sterile physiologic saline. 12. The method of claim 11, wherein in step (b) the jet steam comprises sterile physiologic saline. 13. The method of claim 11, further comprising cutting the prewashed bone with a high pressure focused water jet stream, the high pressure being adjusted to cut bone in the range of 100 to 600 MPa. 14. The method of claim 1, wherein in the step (d) the re-washing under high hydrostatic comprises re-washing with oxygenated or carbonated solutions, under high pressure in the range of 100 to 600 MPa. 15. The method of claim 14 wherein the solutions are carbonated solutions.

Details for Patent 10,004,819

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2039-09-23